Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Viscogliosi Brothers, LLC

https://www.vbllc.com/

Latest From Viscogliosi Brothers, LLC

‘Future Protect': Shoring Up Clinical Programs Against Changes In Standard Of Care

Contract research organization leaders weigh in on how to avoid some recent pitfalls seen at US FDA advisory committee panels.

Advisory Committees Clinical Trials

Deal Watch: ICON, PRA Health Form Massive CRO In $12bn Merger

Plus deals involving Sanofi/SIRION, Merck KGAA/Day One, Beijing Tide/Graviton, Vaccinex/Surface Oncology, Athena/Tris, Biomunex/Onward, Cellectis/Cytovia

Deals M & A

COVID-19 Vaccine Race: With Moderna EUA, US FDA Finally Gets Some Bragging Rights

US FDA’s global first for Moderna’s vaccine gets a small mention as agency looks to pharmacovigilance, follow-up studies for both coronavirus inoculations that have now been authorized. Moderna's 18 December EUA comes after an even faster review than for Pfizer/BioNTech's vaccine.

Coronavirus COVID-19 FDA

Pfizer COVID Vaccine Trial Proved Remote Monitoring, Other Innovations Work, ICON CEO Says

Steve Cutler, head of the CRO that conducted Pfizer’s study, tells the Pink Sheet that starting clinical trials in weeks, as opposed to months, should be possible post-pandemic.

Coronavirus COVID-19 Vaccines
See All

Company Information

  • Other Names / Subsidiaries
    • Viscogliosi Bros., LLC
UsernamePublicRestriction

Register